The treatment is not deemed cost effective for people with a type of advanced prostate cancer.
The findings could eventually lead to new therapies for other cancers.
Exploiting tumor-suppressing RNA
It is important that personalized care pathways ameliorate the patients’ cancer experience and provides them with a roadmap back to living life as normal.
A new model might improve quality of life and prevent over-treatment
Annual prostate-specific antigen screening among Black men might help reduce disparities in prostate cancer mortality, study findings suggest.